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Abstract

Drugs do not act solely by canonical ligand–receptor binding interactions. Amphiphilic drugs partition
into membranes, thereby perturbing bulk lipid bilayer properties and possibly altering the function of
membrane proteins. Distinguishing membrane perturbation from more direct protein–ligand interactions

is an ongoing challenge in chemical biology. Herein, we present one strategy for doing so, using
dimeric 6-bromo-2-mercaptotryptamine (BrMT) and synthetic analogues. BrMT is a chemically unstable
marine snail toxin that has unique effects on voltage-gated K+ channel proteins, making it an attractive
medicinal chemistry lead. BrMT is amphiphilic and perturbs lipid bilayers, raising the question of
whether its action against K+ channels is merely a manifestation of membrane perturbation. To
determine whether medicinal chemistry approaches to improve BrMT might be viable, we synthesized
BrMT and 11 analogues and determined their activities in parallel assays measuring K+ channel activity
and lipid bilayer properties. Structure–activity relationships were determined for modulation of the Kv1.4
channel, bilayer partitioning, and bilayer perturbation. Neither membrane partitioning nor bilayer
perturbation correlates with K+ channel modulation. We conclude that BrMT’s membrane interactions
are not critical for its inhibition of Kv1.4 activation. Further, we found that alkyl or ether linkages can
replace the chemically labile disulfide bond in the BrMT pharmacophore, and we identified additional
regions of the scaffold that are amenable to chemical modification. Our work demonstrates a strategy
for determining if drugs act by specific interactions or bilayer-dependent mechanisms, and chemically
stable modulators of Kv1 channels are reported.

Biological membranes are composites of lipid bilayers and embedded proteins. It has long
been known that membrane protein function is sensitive to the composition of the host
bilayer.(1−4) Commonly, drugs that modulate membrane proteins are presumed to target
proteins, while in fact many act by changing the bulk properties of the host bilayer, thereby
altering membrane protein conformational equilibria.(5−8) Modulators that act by bilayer
perturbation promiscuously modulate a broad spectrum of unrelated membrane
proteins.(6,7,9−15) Upon interpretation of the mechanisms underlying the physiological actions of
a drug, it thus becomes crucial to determine whether the action of an amphiphilic modulator
may involve bulk bilayer perturbation, in addition to more specific interactions.
A prominent example of the importance of understanding drug mechanism involves capsaicin,
a natural product of chili peppers that stimulates mammalian peripheral neurons to evoke a
sensation of burning heat. Capsaicin perturbs bilayers and modulates a wide variety of
membrane proteins, including Na+, K+, and TRP channels. Capsaicin modulates voltage-gated
Na+ and K+ channels via lipid bilayer perturbation,(5,7) but capsaicin also has a specific receptor
site on TRPV1.(16) Medicinal chemistry approaches have been successful in generating
analogues of capsaicin that are selective TRPV1 inhibitors.(17) Similar efforts to selectively
modulate Na+ or K+ channels with capsaicin analogues would be foolhardy, however, because
modulation of membrane proteins via bilayer perturbation is fundamentally promiscuous. Thus,
determining if lipid bilayer perturbation underlies modulation of a target is critical for the
prediction of undesired effects on other membrane proteins.
Because lipophilic and amphiphilic drugs, by their chemical nature, partition into membranes
and perturb the function of transmembrane proteins, it is a significant challenge to determine
whether bilayer perturbation is the relevant mechanism underlying modulation of any particular
target protein. To identify whether drugs operate by a bilayer mechanism, we previously
developed a method of testing modulators for promiscuous activity against multiple unrelated
classes of membrane proteins.(7) Although this method is effective, it requires significant
resources and expertise with many membrane protein preparations. Herein, we report a
greatly simplified strategy for using the structure–activity relationships (SARs) of a modulator

against a single target of interest, in combination with synthetic membrane assays, to dissect
the effects of bulk bilayer perturbation from those of direct protein binding.
The medicinal chemistry target in this study is the natural product ion channel modulator
dimeric 6-bromo-2-mercaptotryptamine (BrMT, 1a). A component of the defensive mucus of
the marine snail Calliostoma canaliculatum, it inhibits voltage-gated K+ channels of the Kv1
and Kv4 subfamilies.(18) BrMT is an allosteric modulator that inhibits channels by slowing the
voltage activation steps that precede pore opening, without blocking the central channel
pore.(19,20) Allosteric modulators of Kv channels are valuable not only as research tools but also
potentially as therapeutics.(21,22) BrMT itself has limited utility because it contains a chemically
labile disulfide bond that is degraded by light and reducing conditions.(19) BrMT is thus an
attractive target for medicinal chemistry efforts to improve its stability.
Several observations suggest that the activity of BrMT against Kv channels may be affected by
nonspecific membrane partitioning. First, high concentrations of BrMT applied to outside-out
membrane patches disrupt the patch clamp seal.(19) Second, a series of chimeras between the
BrMT-sensitive Shaker Kv channel and the insensitive Kv2.1 channel suggest that the region
imparting sensitivity is in the S1, S2, and/or S3 transmembrane regions of sensitive
channels.(23) Third, the wash-in and wash-out kinetics of BrMT are multiphasic, suggesting
slow accumulation of BrMT in the cell membrane during prolonged exposures.(23,24) Together,
these effects are consistent with BrMT partitioning in and out of cell membranes and acting
through the membrane to alter channel function. Similar to many other amphiphilic molecules
that act by bilayer perturbation, the biological effect of BrMT, with its two aminoethyl groups,
depends on the side of the membrane to which it is applied.(25−28) BrMT slows Kv channel
voltage activation only when applied from the extracellular side of the membrane,(19)
suggesting that its two positive charges may prevent it from crossing the membrane entirely.
Certain Kv modulator peptides from animal venoms partition into, but do not cross, the outer
leaflet of the plasma membrane bilayer. Many of these peptides bind to the transmembrane
voltage sensor domains of the channels.(29−31) However, other closely related venom peptides
modulate ion channels via bilayer perturbation.(32) It remains unclear whether BrMT modulates
K+ channels by direct channel binding, by perturbing the bilayer in an indirect manner, or a
combination of both.(33) To elucidate the mode of action of BrMT and potentially improve its
properties as a lead compound for future mechanistic or therapeutic studies, we synthesized a
series of analogues, including several with stable disulfide replacements. The resulting SARs
were assessed separately in membrane partitioning, perturbation, and ion channel assays to
test whether specific or nonspecific interactions drive K+ channel activities with these bis-indole
compounds.

Materials and Methods
The Supporting Information contains detailed descriptions of the synthesis of all BrMT
analogues, cell culture, electrophysiology, gramicidin-based fluorescence quench assay, and
isothermal titration calorimetry.

Results
Synthesis of Novel BrMT Analogues
To determine the minimal structural features required for modulation of Kv channels with BrMT
(1a), we designed a flexible synthesis that would enable facile modification of the tryptamine
scaffold as well as the disulfide linker (Scheme 1). Our synthetic route is similar to that
reported by Gallin and Hall.(34) 6-Bromotryptamine (4) was prepared from 6-bromoindole
according to the sequence reported by Davidson.(35) Protonation of 4 with trichloroacetic acid,
followed by reaction with freshly distilled S2Cl2,(36,37) yielded a mixture of mono-, di-, and
trisulfides 1a–c that was characterized by LC-MS. Using a protocol reported by Showalter for
the preparation of bisindole diselenides as tyrosine kinase inhibitors,(38) we increased the yield
of the desired disulfide product 1a by treating the mixture with sodium borohydride to reduce
the di- and trisulfides. Extraction of the nonpolar monosulfide 1c with ether from the basic
aqueous solution of the resulting indole-2-thiolate, followed by oxidation of the thiolate with
hydrogen peroxide, gave the disulfide 1a, which was purified by semipreparative HPLC and
treated with HCl in dioxane to yield the bis-hydrochloride salt. Five different tryptamines were
prepared via variations of literature protocols (see the Supporting Information for details), and
these were transformed into the analogous bistryptamine-disulfides 5–8 (Table 1) according to
the sequence of reactions in Scheme 1.

Scheme 1. Total Synthesis of BrMT

Table 1. Compilation of Properties of BrMT Derivatives

a

Calculated as the best fit for inhibition of Kv1.4 ± standard deviation of the parameter fit.
Calculated using ChemAxon MarvinSketch version 17.4.3.0.
c
KPW→L is the equilibrium constant for partitioning from water to lipid. Calculated as the geometric mean
± positive standard error.
d
Gramicidin A (gA) channel activity, as measured by the rate of quenching of intravesicular ANTS
fluorescence by Tl+. gA2 fits are shown in Supporting Information Figure S2.
e
Indicates IC50 or gA2 was not measured (highest concentration tested in parentheses).
b

The relative instability of bistryptamine-disulfides, and their potential for disulfide exchange
reactions in vivo,(39) inspired us to explore the use of alternative linkers between the indole
moieties. Several two-carbon indole linkers have been reported in the literature,(40,41) but we
expected that these would be too rigid and/or short to be effective disulfide replacements.
Accordingly, we pursued a convergent synthesis of symmetrical bis-indoles by reacting
suitable aniline derivatives with bis-alkynes. Dipropargyl ether was selected as our first choice,
as it could provide a three-atom, ether-based linker between the two indole rings that would
provide a distance between indole moieties comparable to that of the disulfide linker.
The optimized synthesis of the ether-linked compounds is given in Scheme 2. Commercially
available 4-bromo-2-nitroaniline was subjected to a Sandmeyer reaction(42) to yield aryl iodide
9d in 94% yield. The nitro group of 9d was reduced to aniline 9a using SnCl2 and concentrated
HCl, followed by N-acylation with acetic anhydride to provide the amide 9c. Amide 9c was
subjected to the double Sonogashira cross coupling conditions (Table S1, entry 7) to yield the
bis-alkyne 10c in 90% yield. Treatment of 10c with aqueous TBAF followed by amide
hydrolysis gave 11 (see SI for details). Alkylation of the bis-indole 11 with Eschenmosher’s
salt(43) gave the bis-gramine 12 in excellent yield. Owing to the potential instability of 12, it was
converted without purification to bis-nitrile 13 upon treatment with excess iodomethane and
sodium cyanide in DMF. Reduction of the nitrile groups in 13 with LiAlH4 was problematic and
led to partial reduction of the aryl bromide, but reduction of 13 with alane(44) proceeded
smoothly to give the bis-amine 14 (termed BrET) in 45% yield. Acetylation of 14 with acetic
anhydride furnished the bis-amide 15 in 60% yield. The related BrMT analogues 16–19 (Table
1) were prepared by a sequence of reactions similar to those depicted in Scheme 2. Initial
attempts to reduce 19 to the corresponding diamine were unsuccessful in generating a
compound of acceptable purity.

Scheme 2. Synthesis of Ether-Linker Analogues 14 (BrET) and 15

BrMT Derivatization Alters the Potency of Ion Channel Modulation
We assessed the modulatory effects of BrMT analogues on currents through voltage-gated
potassium channels. To measure the dose–response relations of many compounds in parallel,
we developed an automated whole-cell voltage clamp assay against a BrMT-sensitive ion
channel. BrMT inhibits Kv1 (Shaker-type) channels from invertebrates and vertebrates.(18)
Among members of the Kv1 family, Kv1.4 was chosen because it is a potential target for
chronic pain and lacks high-affinity modulators.(45−48) Moreover, Kv1.4 is transported efficiently
and reliably to the plasma membrane in mammalian cell lines, making it optimal for automated
electrophysiology.(49,50) We therefore created a CHO-K1 cell line with a tetracycline-inducible
expression of Kv1.4 to provide a scalable cell culture with consistent current levels amenable
to automated patch clamp methods.
Amphiphilic drugs often have variable potencies in different experimental preparations. This
preparation-dependent variability may stem from membrane partitioning that is sensitive to the
exact composition of the cell membrane, solution flow, and other factors.(24,51,52) Not
surprisingly, BrMT has different potencies against Shaker Kv1 channels in patches and wholecell voltage clamp of HEK cells, CHO cells, and Xenopus oocytes.(23) To serially compare the
effects of BrMT derivatives with minimal variability, the assays were conducted with a
commercially available automated patch clamp system that applied consistent solution flow for
different experiments.
When BrMT was applied to voltage-clamped cells expressing Kv1.4, it inhibited the currents by
slowing gating kinetics and reducing peak currents (Figure 1A). The effects of BrMT on kinetics
were quantified by fitting a double exponential to the rise and decay of the current after a
depolarizing voltage step (Figure 1B). Increasing concentrations of BrMT progressively slowed
the gating kinetics (Figure 1C). These effects are similar to those seen with Shaker Kv1
channels.(19) BrMT has two phenomenological effects on Kv1 channels: a slowing of activation
kinetics and a diminishment of peak current amplitude after a voltage step.(19) Peak current
amplitudes of Kv1.4 are affected more dramatically than the rate of channel activation by BrMT
(Figures 1, 2A). This greater sensitivity of the peak amplitudes may be due to a stronger
coupling between activation and inactivation in Kv1.4 as compared to Shaker channels.(53) For
comparison among the BrMT analogues, we therefore used the IC50 values determined from
the changes in peak current because their fitting was better constrained than the results
obtained from the more complex curve fitting procedures needed to analyze the activation
kinetics. Modulation of Kv1.4 currents is apparent over a range of concentrations (Figure S1),
and IC50 estimates were successfully obtained for most BrMT analogues (Figure 2). The Hill
slopes deduced from these fits are between 1 and 2 for most analogues. Hill slopes greater
than 1 could arise from cooperative interactions of the BrMT analogue with multiple subunits of
Kv channels.(20) One analogue, 15, has a lower Hill slope, which could indicate that this weakly
modulating analogue acts by a different mechanism, but its low potency precludes any
significant interpretations.

Figure 1. BrMT inhibits Kv1.4 channel activation. (A) Kv1.4 current responses to indicated BrMT
concentrations during voltage steps from −100 to 0 mV. (B) Kv1.4 current responses. Colored lines
correspond to the same BrMT concentrations as in panel A. Stippled lines are fits of eq 2, in the
Supporting Information. Voltage steps from −100 to 0 mV. Vehicle τact = 1.72 ± 0.02, τinact = 67.3 ± 0.2;
1.5 μM τact = 2.54 ± 0.02, τinact = 136.6 ± 0.6; 3 μM τact = 3.17 ± 0.03, τinact = 181 ± 2; 6 μM τact = 4.2 ±
0.4, τinact = 300 ± 20. (C) Time constants of activation (filled circles) and inactivation (empty circles).
Error bars indicate SEM (n = 9). Stippled lines are fits for Kd, as in ref (19).Kd from τact = 2.9 ± 1.0 μM,
and Kd from τinact = 1.6 ± 0.7 μM.

Figure 2. Structure–activity relationship of Kv1.4 inhibition. Average inhibition of peak Kv1.4 currents as
a function of concentration. The shapes and colors of markers correspond to compounds with
modifications indicated by shapes in the left column. Error bars indicate SEM. Lines are fits of eq 1, in
the Supporting Ingormation, with parameter values indicated in Table 1. The color and pattern of lines
correspond to compounds with modifications indicated by the shapes in the left column. (A) BrMT and
analogues with modifications at the 6-positions on the indole rings. (B) Analogues with modifications of
the disulfide linker and amines. (C) Ineffective analogues without aminoethyl groups.

Factors affecting channel inhibition emerge from analysis of SAR data. Replacement of the 6bromo moiety of BrMT with a chloro or methyl group as in 5 and 7 had little effect on inhibitor
potency, whereas substitution with the smaller and more electronegative fluoro group as in 6
led to a decrease in potency by an order of magnitude (IC50 = 26 μM). Prior measurements
with a BrMT analogue containing only a hydride at position 6 indicated that it was also an order
of magnitude less potent than BrMT against Shaker K+ channels.(54) Moving the bromo group
to the 5-position on the indole ring as in 8 had only a minor effect on potency. These results
suggest that variable indole substituents are tolerated.
BrMT loses its potency against Kv channels when the disulfide is reduced to form monomeric
compounds.(19) On the other hand, the disulfide linkage between the indole groups is

remarkably tolerant to replacement. For example, activity is retained when the disulfide moiety
in BrMT is replaced with the ether linkage in 14 or when the disulfide in the 6-chlorosubstituted analogue 5 is replaced with the trimethylene linker in 16. The idea that alterations
in the linker between the indoles have only mild effects on Kv potency was also reported by
Gallin and Hall,(34) who found that Kv1 channel inhibition was maintained for 1a–c, wherein the
number of sulfur atoms bridging the indole rings was varied from one to three.
The discovery that Kv inhibition is retained with an ether or alkyl linkage between the indole
rings permitted additional SAR studies using these more chemically stable scaffolds. We found
that compounds 11, 18, and 19, which each lack the aminoethyl side chain, are inactive at the
highest concentrations tested. Moreover, the N-acetyl derivative 15 and the N,Ndimethylaminoethyl analogue 17 are less potent than the parent compound BrET (14) by more
than an order of magnitude. Collectively, these results indicate that modification at the 2- and
6-positions of the indole rings of BrMT is well-tolerated, but the aminoethyl groups at the 3positions are critical for channel activity: compounds lacking basic side chains at the 3-position
were inactive (e.g., 11, 18, and 19).

BrMT Derivatization Alters Bilayer Partitioning, but Partitioning Does Not Predict
Ion Channel Modulation
We measured the degree to which the BrMT analogues partition into membranes using
isothermal titration calorimetry (ITC).(55) These experiments were conducted with suspensions
of large unilamellar phospholipid vesicles (LUVs) (see SI) as a surrogate for the bilayer
component of cell membranes. All of the analogues partitioned into the bilayer with water →
bilayer partition coefficients (KPW→L) ranging between 450 and 3900 (Table 1); the calculated
log([n-octanol]/[water]) (ClogP) values are also listed for comparison. KPW→L values increased
when the disulfide linkage was replaced with a three-atom alkyl or an ether linkage. For
example, replacing the disulfide linkage of BrMT (1a) (KPW→L = 560) with an ether linkage as in
14 (KPW→L = 3100) led to an increase in KPW→L values, as did replacing the disulfide bridge of
the chloro analogue 5 (KPW→L = 1000) with a trimethylene linkage in 16 (KPW→L = 3300). If
channel modulation results from compounds partitioning into the membrane bilayer, we would
expect that the Kv1.4 IC50 values would correlate with the KPW→L values, but this is not the
case (Figure 3). Examination of small structural changes that influence partitioning and/or
channel modulation also indicates that the two properties are independent. Replacing the
disulfide linkage of BrMT (1a) with the ether moiety in 14 increases KPW→L values but has little
impact on IC50. The acetylated, nonbasic compound 15 has an increased fraction in
membranes vs its basic parent 14 (KPW→L = 3900 vs 3100), but its potency against Kv1.4 drops
substantially (IC50 = 70 μM vs 2.7 μM) (Figure 3, brown arrows). Replacing the disulfide linkage
of 5 with a trimethylene linkage in 16 also increases KPW→L values with little impact on IC50.
Comparison of 16 to the related N,N-dimethylaminomethyl compound 17 shows a rare
example of a relatively minor structural change that simultaneously decreases both the KPW→L
values and inhibitory potency (Figure 3, green arrows). Overall, increases in the partition
coefficient were not coupled to an increase of inhibitory potency. Fitting a linear regression to

KPW→L and IC50 values did not yield any significance (r = 0.34, p = 0.37). The fraction of a BrMT
analogue in the bilayer does not correlate with its potency, which suggests that bilayer
partitioning is not sufficient for Kv channel modulation.

Figure 3. Membrane partition coefficients do not predict channel inhibition. Numbers by each marker
denote the analogue identity. The shape and color of markers correspond to Figure 2. Values are from
Table 1. Black arrows denote analogues with such a low activity that we could not measure it (null
response), with the marker indicating the highest concentration tested. Brown and green arrows with
dashed lines indicate modification of the disulfide linker. Brown and green arrows with dotted lines
indicate modification of aminoethyl groups.

Membrane Perturbation by BrMT Derivatives Is Not Correlated with Bilayer
Partitioning
Bilayer partitioning itself did not underlie the variable potencies of Kv channel inhibitors, but it
remains a possibility that nonspecific bilayer perturbation might affect their inhibition of Kv1.4
because small membrane-perturbing amphiphiles are known to inhibit many Kv channels.(7)
We therefore probed for bilayer-modifying effects using a gramicidin A (gA)-based

fluorescence assay that monitors changes of gA activity in LUVs.(56,57) This assay exploits the
gramicidin channel-permeant thallous ion (Tl+), which quenches the fluorescence of the watersoluble fluorophore 8-aminonaphthalene-1,3,6-trisulfonate (ANTS). gA permits transmembrane
Tl+ flux only as a dimer, and the equilibrium between monomeric and dimeric gA is altered by
lipid bilayer perturbation. ANTS fluorescence is measured after addition of Tl+ to a suspension
of ANTS-loaded gA-containing LUVs, and the time course of fluorescence quenching (Figure
4A) provides a measure of the changes in intravesicular [Tl+]. The initial rate of fluorescence
quenching provides a measure of the initial rate of Tl+ influx into the LUVs,(58−60) which varies
with changes in the number of dimeric gA molecules in the LUV membrane. It is thus possible
to determine how a drug, or other amphiphile, shifts the gA monomer/dimer equilibrium, which
provides a measure of the bilayer-modifying potency of the molecule of interest. The BrMT
analogue concentration that elicits a doubling of the rate of gA-dependent quenching is
denoted as gA2 and serves as a metric for the bilayer-perturbing potency (Figure S2). Note
that a lower gA2 concentration indicates more potent bilayer perturbation. Some noticeable
structural trends were observed (Table 1). Analogues 11 and 18 that lack aminoethyl side
chains did not have a measurable gA2 because they caused no changes in the quench rate at
the highest concentration tested. This result indicates that these analogues have minimal
effects on bilayer properties. The linkage between the tryptamine monomers also affected
bilayer perturbation. For example, the ether-linked derivatives 14 and 15 had the lowest gA2,
and replacing the disulfide linkage of 5 with a trimethylene chain as in 16 did not detectably
change gA2. Other changes to the aminoethyl side chains as shown by 14 vs 15 and 16 vs 17
increased the bilayer-modifying potency.

Figure 4. Membrane perturbation is distinct from partitioning and does not predict channel inhibition. (A)
Gramicidin A (gA) channel activity, as measured by the rate of quenching of intravesicular ANTS

fluorescence by Tl+. For each trace, the gray dots denote the results obtained in the nine individual
repeats, whereas the colored dots denote the average value at each time point. (B) Membrane
partition–perturbation relationships. Numbers next to the different markers denote the analogue’s
identity. The shape and color of markers are as in Figure 2. Data from Table 1. Black arrows indicate a
null response, with the marker indicating the highest concentration tested. Brown and green arrows with
dashed lines indicate modification of the disulfide linker. Brown and green arrows with dotted lines
indicate modification of aminoethyl groups. (C) Membrane perturbation–inhibition relationship (data
from Table 1).

Bilayer partitioning did not predict the bilayer-perturbing potency, as there was no obvious
correlation between KPW→L and gA2 (Figure 4B) (r = −0.27, p = 0.47). Divergent effects of
structure on KPW→L and gA2 can also be seen when comparing the related analogues 1a vs 14
and 15, as well as 5 vs 16 and 17. For compounds 1a, 14, and 15, a decreasing gA2 was
consistent with an increasing KPW→L, as would be expected if an increase in the partition
coefficient decreased the aqueous concentration needed to reach a mole fraction in the bilayer
that caused the perturbation. Substituting an ether linkage into 1a giving 14, for example,
increased bilayer partitioning and perturbation. When the aminoethyl groups in 14 are
acetylated to give 15, there is a further slight increase of bilayer partitioning and perturbation
(Figure 4B, brown arrows). However, in a sequence of modifications at the same positions of
the Cl-substituted disulfide in the series 5, 16, and 17, gA2 appeared insensitive to KPW→L (5 →
16, Figure 4B, stippled green arrows) and then anticorrelated (16 → 17). A particularly striking
example of the divergence between gA2 and KPW→L is seen when the bromo group at C6 in 1a
is moved to C5 in 8, resulting in a moderate increase in KPW→L yet complete inactivity in the gA
assay (Figure 4A, right panel). Overall, BrMT analogues did not show a consistent
dependence of bilayer perturbation on partitioning.

Potency of Channel Modulation Is Not Dictated by Bilayer Perturbation
Bilayer perturbation was altered by BrMT analogues in a fashion distinct from partitioning, so
we then assessed whether perturbation might be the mechanism underlying Kv modulation.
When Kv1.4 IC50 values are plotted vs gA2 values as a measure of bilayer perturbation, there
is no obvious correlation (r = −0.37, p = 0.36) (Figure 4C). In fact, more potent bilayerperturbing compounds are generally weaker inhibitors of Kv1.4. Substitution of the native
disulfide linkage of 1a for the ether linker in 14 led to a 10-fold decrease in gA2 (10-fold
increase in bilayer-perturbing potency) with a slight decrease in potency of channel inhibition
(IC50 = 2.7 μM for 14 vs 1.1 μM for 1a). In contrast, when the disulfide linkage in the 6-chloro
analogue 5 is replaced with the trimethylene linker in 16, there is little change in gA2, but there
is a 3-fold increase in IC50. Changes to the aminoethyl side chain (e.g., 14 → 15 or 16 → 17)
decrease gA2 but increase IC50 (Figure 4C). Notably, analogue 8, which does not perturb
bilayers at the highest concentration tested, is a strong modulator of Kv1.4, whereas the most
bilayer-perturbing analogue 15 is a weak modulator of Kv1.4 channels. Inspection of the
current traces recorded in the presence of 15 reveals that inactivation is accelerated. This
action is consistent with prior findings that bilayer-perturbing detergents modulate inactivation
of Kv1 channels(61) and suggests that Kv1.4 modulation by 15 may occur via a mechanism
different from that of the less bilayer-perturbing BrMT analogues.

Discussion
Overall, these relationships show that Kv1.4 inhibition does not correlate with either bilayer
partitioning or bilayer perturbation. We conclude that though BrMT and its analogues that are
active against ion channels all partition into bilayers and usually perturb bilayer properties, the
partitioning and alterations in bilayer properties do not drive potassium channel modulation.
We conclude that specific interactions between Kv1.4 and “strong” modulators such as BrMT
and BrET are critical for activity.

Limitations
Our results show that bilayer partitioning and perturbation are not critical determinants of
modulation of Kv channels by BrMT or its analogues. These conclusions rely on interpretations
that have caveats:
1. The bilayer partitioning and perturbation experiments were conducted with bilayers
formed by synthetic phosphocholine lipids. Results in multicomponent bilayers,(62−64)
and whole cells,(10) have been found to be similar to those obtained in single-component
bilayers. On the basis of these previous validations, we expect the impact of
compounds on single-component bilayers will extend to living cells more generally.
However, our experiments do not exclude the possibility that BrMT derivatives partition
differently into CHO cells and/or interact in a binding pocket with specialized lipids.
2. Our interpretation assumes that the BrMT derivatives alter Tl+ flux through gA
channels by perturbing lipid membranes, not by interacting directly with the gA channel
itself. Our experiments cannot completely exclude such direct effects; results with many
different structurally diverse amphiphiles show that they have similar effects on rightand left-handed channels, which effectively excludes direct interactions.(6,8,65) The
achirality of the BrMT derivatives here precludes such a validation.

Implications
By using a series of analogues of the snail defensive toxin BrMT, we identified certain
molecular features that determine its inhibition of potassium channels as well as its partitioning
into and perturbation of membranes. Our findings are consistent with BrMT acting through a
drug binding pocket at the lipid bilayer–potassium channel interface.(31,66,67) The positive
charges of other amphiphilic, membrane partitioning compounds are crucial for their inhibition
of Kv1 channels,(68) which is consistent with our observations for BrMT and analogues.
Compounds 1a, 5, 7, 8, 14, and 16 each strongly inhibit Kv channels, but of these only the
native compound BrMT (1a) has a minimal impact on membranes. The BrMT analogue 7 is the
only strong Kv1.4 inhibitor that shows a relative decrease in bilayer partitioning and is a more
potent bilayer perturber. On the other hand, 8 is the only strong Kv1.4 inhibitor that is a less
potent bilayer perturber and has a partition coefficient higher than that of BrMT. Thus, all of our
strongly Kv1.4 inhibiting analogues either partitioned into or perturbed the bilayer more than
BrMT. We speculate that membrane partitioning and perturbation may have played a role in
the natural selection of BrMT to be the defensive toxin of the sea snail, possibly because of its

minimal negative impacts on snail membranes. We also conclude that bilayer interactions are
not correlated with inhibition of Kv1.4.

BrMT Analogues as Research Tools
The determination of what conformations ion channels adopt is an ongoing challenge of
molecular physiology. BrMT is a toxin that selectively binds to resting Kv conformations,(19)
making BrMT a powerful tool to explore conformational changes of potassium channels.
Conformation-selective ligands are of increasing importance for associating functional states of
proteins with structurally defined conformations. For example, conformation-selective toxins
were the enabling factors for reconstructing TRPV1 ion channels in an open state,(16,69−71) and
co-crystals of ASIC ion channels with peptide toxin gating modifiers led to the identification of
structures of new channel conformations.(72−74) In functional studies, tagged conformationselective toxins allow imaging of Kv2 channels adopting specific conformations in live
cells.(75,76) BrMT-like compounds similarly can stabilize the resting conformation of Kv1 channel
voltage sensors, and they have the potential to be useful tools for studying channel
conformations in cells and live tissue. The ether-linked analogue BrET (14) identified in this
study is comparable in potency to BrMT but lacks the unstable disulfide moiety of the natural
product. With the information that modifications to the indole ring and the linker between them
are well-tolerated, a path is revealed for generating additional conformation-selective ligands
targeting resting conformations of Kv1 ion channel voltage sensors.
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